Clients typically engage PWR on complex, strategic challenges facing FDA regulated products for which PWR attorneys, scientists, communications and other experts develop and execute solutions. Expected contribution to patient and public health is key to PWR’s selection of new matters. The same criterion is used to identify the firm’s pro bono efforts.
Learn about our editorial policies